The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Limaca Medical for its Precision GI endoscopic ultrasound…
Browsing: Clinical Updates
A study conducted using the Florida Cancer Data System revealed that the causes of hepatocellular carcinoma (HCC) vary significantly based…
Of several potential advances in the treatment of gastrointestinal cancers presented at the 2023 annual meeting of the American Society…
A recent study published in the Annals of Internal Medicine revealed a significant communication gap regarding colorectal cancer (CRC) screening.…
Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon. In North America, its prevalence surpasses 400 per 100,000…
In June 2023, a multisociety group agreed to change the name of the disease formerly known as nonalcoholic fatty liver…
In this edition of “Sharma’s Endoscopy Insights,” I highlight two studies related to resection—an approach to ulcerative colitis–related lesions and…
NEW YORK, Sept. 7, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary…
A recent clinical trial has indicated that using resistant starch as a microbiota-directed dietary supplement could be a promising intervention…
The article delves into the potential of fecal microbiota transplantation (FMT) as a treatment for ulcerative colitis (UC). A comprehensive…